Intracellular domains of CXCR3 that mediate CXCL9, CXCL10, and CXCL11 function

被引:198
|
作者
Colvin, RA [1 ]
Campanella, GSV [1 ]
Sun, JT [1 ]
Luster, AD [1 ]
机构
[1] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Div Rheumatol Allergy & Immunol, Boston, MA 02129 USA
关键词
D O I
10.1074/jbc.M403595200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The chemokine receptor CXCR3 is a G protein-coupled receptor found predominantly on T cells that is activated by three ligands as follows: CXCL9 (Mig), CXCL10 (IP-10), and CXCL11 (I-TAC). Previously, we have found that of the three ligands, CXCL11 is the most potent inducer of CXCR3 internalization and is the physiologic inducer of CXCR3 internalization after T cell contact with activated endothelial cells. We have therefore hypothesized that these three ligands transduce different signals to CXCR3. In light of this hypothesis, we sought to determine whether regions of CXCR3 are differentially required for CXCL9, CXCL10, and CXCL11 function. Here we identified two distinct domains that contributed to CXCR3 internalization. The carboxyl-terminal domain and beta-arrestin1 were predominantly required by CXCL9 and CXCL10, and the third intracellular loop was predominantly required by CXCL11. Chemotaxis and calcium mobilization induced by all three CXCR3 ligands were dependent on the CXCR3 carboxyl terminus and the DRY sequence in the third trans-membrane domain. Our findings demonstrate that distinct domains of CXCR3 mediate its functions and suggest that the differential requirement of these domains contributes to the complexity of the chemokine system.
引用
收藏
页码:30219 / 30227
页数:9
相关论文
共 50 条
  • [1] CXCL9, CXCL10, CXCL11, and their receptor (CXCR3) in neuroinflammation and neurodegeneration
    Koper, Olga M.
    Kaminska, Joanna
    Sawicki, Karol
    Kemona, Halina
    [J]. ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 27 (06): : 849 - 856
  • [2] CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy
    Tokunaga, Ryuma
    Zhang, Wu
    Naseem, Madiha
    Puccini, Alberto
    Berger, Martin D.
    Soni, Shivani
    McSkane, Michelle
    Baba, Hideo
    Lenz, Heinz-Josef
    [J]. CANCER TREATMENT REVIEWS, 2018, 63 : 40 - 47
  • [3] Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation
    Flier, J
    Boorsma, DM
    van Beek, PJ
    Nieboer, C
    Stoof, TJ
    Willemze, R
    Tensen, CP
    [J]. JOURNAL OF PATHOLOGY, 2001, 194 (04): : 398 - 405
  • [4] Comparative Expression of CXCR3 Chemokine Receptor and Their Ligands (CXCL9, CXCL10 and CXCL11) in Cutaneous Melanoma Progression
    Pellin-Carcelen, A.
    Ramos, D.
    Martin, J.
    Jordc, E.
    Pellin, A.
    Monteagudo, C.
    [J]. MODERN PATHOLOGY, 2009, 22 : 108A - 108A
  • [5] Comparative Expression of CXCR3 Chemokine Receptor and Their Ligands (CXCL9, CXCL10 and CXCL11) in Cutaneous Melanoma Progression
    Pellin-Carcelen, A.
    Ramos, D.
    Martin, J.
    Jorda, E.
    Pellin, A.
    Monteagudo, C.
    [J]. LABORATORY INVESTIGATION, 2009, 89 : 108A - 108A
  • [6] CCR3 functional responses are regulated by both CXCR3 and its ligands CXCL9, CXCL10 and CXCL11
    Xanthou, G
    Duchesnes, CE
    Williams, TJ
    Pease, JE
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (08) : 2241 - 2250
  • [7] Review: The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity - a tale of conflict and conundrum
    Mueller, M.
    Carter, S.
    Hofer, M. J.
    Campbell, I. L.
    [J]. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2010, 36 (05) : 368 - 387
  • [8] The Serum Level of CXCL9, CXCL10, and CXCL11 and the Expression of CXCR3 of Peripheral Blood Mononuclear Cells in Brucellosis Patients
    Farzaneh Hassanshahi
    Mojgan Noroozi Karimabad
    Elahe Miranzadeh
    Gholamhossein Hassanshahi
    Seyedeh Atekeh Torabizadeh
    Ali Jebali
    [J]. Current Microbiology, 2023, 80
  • [9] The Serum Level of CXCL9, CXCL10, and CXCL11 and the Expression of CXCR3 of Peripheral Blood Mononuclear Cells in Brucellosis Patients
    Hassanshahi, Farzaneh
    Karimabad, Mojgan Noroozi
    Miranzadeh, Elahe
    Hassanshahi, Gholamhossein
    Torabizadeh, Seyedeh Atekeh
    Jebali, Ali
    [J]. CURRENT MICROBIOLOGY, 2023, 80 (06)
  • [10] Modelling of the membrane receptor CXCR3 and its complexes with CXCL9, CXCL10 and CXCL11 chemokines: Putative target for new drug design
    Trotta, Tiziana
    Costantini, Susan
    Colonna, Giovanni
    [J]. MOLECULAR IMMUNOLOGY, 2009, 47 (2-3) : 332 - 339